Task: Answer the multiple choice question.
Question: Which compound exhibits a -8.709% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a: Cc1ccc(CCNC(=O)C2CCN(C(=O)c3sccc3-n3cccc3)CC2)cc1
b: S=C(Nc1ccccc1)N1CCN(C/C=C/c2ccccc2)CC1
Answer: b. S=C(Nc1ccccc1)N1CCN(C/C=C/c2ccccc2)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
S=C(Nc1ccccc1)N1CCN(C/C=C/c2ccccc2)CC1
S=C(Nc1ccccc1)N1CCN(C/C=C/c2ccccc2)CC1
N-phenyl-4-[(E)-3-phenylprop-2-enyl]piperazine-1-carbothioamide